Nectin-4 has shown clinical significance in serological and molecular imaging diagnosis of some tumor types, such as ovarian cancer, urothelial carcinoma, and breast cancer, but more studies with larger sample sizes are needed to promote its further applications. This evidence concerns the gene NECTIN4 and breast cancer.